Parisi Gray Wealth Management Esperion Therapeutics, Inc. Transaction History

Parisi Gray Wealth Management

  • $301 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021
SELL
$11.34 - $21.37 $2,041 - $3,846
-180 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$19.4 - $28.71 $3,491 - $5,167
180 New
180 $4,000
Q2 2019

Jul 19, 2019
SELL
$40.1 - $52.33 $7,218 - $9,419
-180 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$43.47 - $67.43 $7,824 - $12,137
180
180 $12,000

Others Institutions Holding ESPR

# of Institutions
207
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $155M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Parisi Gray Wealth Management Portfolio

Follow Parisi Gray Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parisi Gray Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Parisi Gray Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email